ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ubiquitech Software's Subsidiary, Innovative Outcomes, Revolutionizes Healthcare Landscape With Clinic-Based Model, Anticipates Surge in Revenue Growth

DENVER, CO - (NewMediaWire) - April 10, 2024 - Ubiquitech Software Corp. (OTC: UBQU), an innovative force in software development, is proud to announce a game-changing initiative by its subsidiary, Innovative Outcomes. The addition of a “Clinic-Based” focus to its business model represents a new era of exponential revenue growth, with each "Clinic Model" poised to inject an additional one million dollars annually into Innovative Outcomes' revenue stream.

Embracing the Clinic-Based Model, Innovative Outcomes has crafted a pioneering system tailored to empower established wound care clinics nationwide. By facilitating order submission, enhancing patient engagement, and streamlining clinical note transmission, the company positions itself as a catalyst for direct prescription facilitation through its dedicated personnel. This streamlined approach not only optimizes operational efficiency but also expedites insurance claim processing, ensuring seamless product delivery to the patient.

Innovative Outcomes is aggressively forging ahead with plans to establish 3-5 models by the close of the 3rd quarter. Additional clinics are slated to be added by the end of 2024. The company anticipates an exponential rollout throughout 2025, cementing its position as an industry leader in healthcare logistics.

Each "Model" represents a significant revenue boost, estimated at one million dollars annually, increasing the company’s market share in  the wound care segment of US healthcare. Kevin Lamb, CEO of Innovative Outcomes, expressed his enthusiasm, stating, "Our clinic-focused approach signifies a paradigm shift in healthcare delivery, elevating service standards and enhancing regulatory compliance. This initiative marks another pivotal step towards innovation within the wound care space, while realizing our ambitious goal of achieving our goal of $100 million in annual revenue."

For exclusive insights from Kevin Lamb regarding Innovative Outcomes' trajectory and projected growth, access the interview from April 4th here.

Stay connected with Ubiquitech Software Corp., Inc. to remain abreast of Innovative Outcomes' milestones and the company's overall evolution:

      Innovative Outcomes Inc.: www.ioutcomes.com

      Ubiquitech Software Corp.: www.UbiquitechsoftwarecorpCorp.com

      Follow UBQU on X (Formerly Twitter): @CorporateUBQU

      Follow Innovative Outcomes on X (Formerly Twitter): @i_outcomes

About Ubiquitech Software Corp.:

Ubiquitech Software Corp. leverages state-of-the-art global internet marketing, Metaverse marketing, Affiliate marketing, Direct Response Television (DRTV), Radio, Internet Content, SEO, and traditional marketing techniques to drive traffic to its subsidiary.

About Innovative Outcomes Inc.:

Innovative Outcomes emerges as one of the fastest-growing healthcare logistics companies, committed to serving medical providers and patients nationwide. Anchored by the ethos of "Patients First," our culture underscores ethics and compassion, simplifying wound care through our iPak – unit dose packaging system. As trailblazers in healthcare technology and logistics, we alleviate healing burdens, ensuring optimal outcomes for all patients.

Safe Harbor:

Please refer to Ubiquitech Software Corporation, Inc.'s annual and quarterly financials for a comprehensive discussion of risk factors. The Company disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise.

Contact / Investor Relations:

IR@UbiquitechSoftwareCorp.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.